Effects of Piroxicam and D-Penicillamine on T Lymphocyte Subpopulations, Natural Killer Cells and Rheumatoid Factor Production in Rheumatoid Arthritis

References

• Zvaifler N J. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 1973; 16: 265–336
   PubMedGoogle Scholar
• Waalen K, Førre Ø, Linker-Israeli M, Thoen J. Evidence of an activated T cell system with augmented turnover of interleukin-2 in rheumatoid arthritis. Stimulation of human T lymphocytes by dendritic cells as a model for rheumatoid T cell activation. Scand J Immunol 1987; 25: 367–73
   PubMed Web of Science ®Google Scholar
• Veys E M, Hermanns P, Schindler J, Kung P C, Goldstein G, Symours J, Wauwe van J. Evaluation of T cell subset with monoclonal antibodies in patients with rheumatoid arthritis. J Rheumatol 1982; 9: 25–29
   PubMed Web of Science ®Google Scholar
• Yu D TY, Winchester R J, Fu S M, Gibofsky A, Ko H S, Kunkel H G. Peripheral blood la-positive T cells. Increases in certain diseases and after immunization. J Exp Med 1980; 151: 91–100
   PubMed Web of Science ®Google Scholar
• Doubloug J H, Førre Ø, Kvien T K, Egeland T, Degre M. Natural killer (NK) cell activity of peripheral blood, synovial fluid and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Ann Rheum Dis 1982; 41: 490–94
   PubMedGoogle Scholar
• Thoen J, Waalen K, Førre Ø. Natural killer (NK) cells at inflammatory sites in patients with rheumatoid arthritis and in IgM rheumatoid factor positive polyarticular juvenile rheumatoid arthritis. Clin Rheumatol 1987; 6: 215–25
   PubMed Web of Science ®Google Scholar
• Pope R M, Lessard J, Nummery E. Differential effects of therapeutic regimens on specific classes of rheumatoid factor. Ann Rheum Dis 1986; 45: 183–99
   PubMed Web of Science ®Google Scholar
• Munthe E, Natvig J B. Immunoglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells. Clin Exp Immunol 1972; 12: 55–70
   PubMed Web of Science ®Google Scholar
• Klein J. Immunology. The science of self- non-self discrimination. John Wiley & Sons Inc., New York 1982
   Google Scholar
• Jacoby R K, Jayson M I, Cosh J A. Onset, early stages of prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow up. Br Med J 1973; ii: 96–100
   Google Scholar
• Appleton R H, Brown K. Conformational requirements at the prostaglandin cyclooxygenase receptor site: A template for designing non-steroidal anti-inflammatory drugs. Prostaglandin 1979; 18: 19–34
   PubMedGoogle Scholar
• Robinson D R, Curran D P, Homer P J. Prostaglandins and related compounds in inflammatory rheumatic diseases. Advances in Inflammatory Research, M Ziff, G P Velo, S Gorini. Raven Press, New York 1982; 2: 17–27
   Google Scholar
• Goodwin J S, Ceuppens J L, Rodrigues M A. Effect of non-steroidal anti-inflammatory agents on immunologic function in patients with rheumatoid arthritis. JAMA 1983; 250: 2485–88
   PubMed Web of Science ®Google Scholar
• Ceuppens J L, Robaeys G, Verdickt W, Vertessen S, Deckmyn H, Dequeker J. Immunomodulatory effects of treatment with Naproxen in patients with rheumatic diseases. Arthritis Rheum 1986; 29: 305–11
   PubMedGoogle Scholar
• Husby G, Holme I, Rugstad H E, Herland O B, Giercksky K E. A double-blind multicenter trial of piroxicam and naproxen in osteoarthritis. Clin Rheumatol 1986; 5: 84–91
   PubMed Web of Science ®Google Scholar
• Hanly J G, Hassan J, Whelan A, Feighery C, Bresnihan B. Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis patients. Arthritis Rheum 1986; 29: 480–87
   PubMed Web of Science ®Google Scholar
• Hill H FH. Treatment of rheumatoid arthritis with penicillamine. Sem Arthr Rheum 1977; 6: 361–72
   PubMed Web of Science ®Google Scholar
• Lipsky P E, Ziff M. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4. J Clin Invest 1980; 65: 1069–74
   PubMed Web of Science ®Google Scholar
• Lipsky P E, Ziff M. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: Synergistic inhibition by D-penicillamine and copper salts. J Immunol 1978; 120: 1006–14
   PubMed Web of Science ®Google Scholar
• Ropes M W, Bennett G A, Cobb S, Jacox R, Jessar R A. 1958 revision of Diagnostic Criteria for Rheumatoid Arthritis. Bull Rheum Dis 1958; 9: 175–76
   PubMedGoogle Scholar
• Bøyum A. Isolation of human lymphocytes, granulocytes and macrophages. Scand J Immunol 1977; 5(Suppl. 5)9–15
   Google Scholar
• Doubloug J H, Førre Ø, Lea T, Solheim B G, Natvig J B. Detection of Fc-receptor-bearing human lymphocytes. The majority of TM cells carry HLA-DR antigens. Clin Immunol Immunopathol 1981; 19: 224–37
   PubMedGoogle Scholar
• Egeland T, Lea T. A rapid rosette technique for quantification and separation of mononuclear cell subsets using monoclonal antibodies. J Immunol Methods 1982; 55: 213–18
   PubMed Web of Science ®Google Scholar
• Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay for immunoglobulin G. Immunochem 1971; 8: 871–78
   PubMedGoogle Scholar
• Vinje O, Førre Ø, Møller P, Mellbye O J. Natural killer (NK) cell activity of peripheral blood lymphocytes from patients with Bechterews syndrome (ankylosing spondylitis). Scand J Rheumatol 1984; 13: 297–300
   PubMed Web of Science ®Google Scholar
• Ritchie D M, Boyle J A, McInnes J M, Greievson P, Buchanan W W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quart J Med 1968; 37: 393–406
   PubMedGoogle Scholar
• Bluestone R, Goldberg L S. Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor. Ann Rheum Dis 1973; 32: 50–52
   PubMed Web of Science ®Google Scholar
• Reinherz E, Schlossman S F. Regulation of the immune response-inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med 1980; 303: 370–75
   PubMed Web of Science ®Google Scholar
• Russel A S, Miller C. The activity of natural killer cells in patients with rheumatoid arthritis: I. The effect of drugs used in vivo. Clin Exp Rheumatol 1984; 2: 227–29
   PubMed Web of Science ®Google Scholar
• Weintraub M, Jacox R F, Angevine C D, Atwater E C. Piroxicam (CP-16,171) in rheumatoid arthritis: A controlled clinical trial with novel assessment techniques. J Rheumatol 1977; 4: 393–404
   PubMed Web of Science ®Google Scholar
• Ceuppens J L, Rodrigues M A, Goodwin J S. Non-steroidal anti-inflammatory agents inhibit the synthesis of IgM rheumatoid factor in vitro. Lancet 1982; i: 528–30
   Google Scholar
• Lanier L L, Le A M, Philips J H, Warner N L, Babcock G F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 1983; 131: 1789–96
   PubMed Web of Science ®Google Scholar
• Kuren H H, Anderson S J, Fischer D, Copeland C A, Jensen P J. Regulation of human natural killing. I. The role of monocytes, interferon and prostaglandins. J Immunol 1981; 127: 2007–13
   PubMed Web of Science ®Google Scholar
• Rola-Pleszczynski M. Immunoregulation by leucotrienes and other lipoxygenase metabolites. Immunol Today 1985; 6: 302–7
   PubMedGoogle Scholar
• Steinbrocker O, Traeger C H. Battermann RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659–63
   PubMed Web of Science ®Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977; 18: 481–91
   PubMed Web of Science ®Google Scholar